EFTA01492817.pdf

FINANCIAL TRUST COMPANY INC ACCT. For the Period 2/1/12 to 2/29/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized GainiLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 14.35 18,535.000 237,277.25 251,475.52 (14,198.27) 04033A-10-0 ARIA BIOGEN IDEC INC 116.47 2,095.000 244,004.65 250,454.95 (6,450.30) 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 86.52 1,000,000 000 865,200.00 1,000,000.00 (134,80000) 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07,1511 MS 21 09 2515A1-A7-6 P FIRST REPUBLIC BANK SAN FRAN 29.99 000 33616C-I0-0 FRC HSBC MARKET PLUS SPX 05117/13 100.03 5,000,000.000 5,001,500.00 5,003,000.00 1,500.00 72% KO BARRIER- 0%CPN ,UNCAPPED INITIAL LEVEL-02/14/12 SPX:1350.50 4042K1-X0-1 P ONEOK PARTNERS LP 58.20 0.00 4.19% 68268N-10-3 OKS JP Morgan Account W23560001 Page 5 of 33 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan JPM-SDNY-00015634 Chase CONFIDENTIAL SDNY_GM_00284832 EFTA01492817